MedTrace Logo

Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION

NCT02470429 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2018-07-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare SYSTANE® HYDRATION to Hyabak 0.15% based on total ocular surface staining scores (TOSS) at Day 42.

Conditions

  • Dry Eye

Interventions

DEVICE

SYSTANE HYDRATION lubricant eye drops

Preserved with POLYQUAD (polidronium chloride) 0.001%

DEVICE

Hyabak 0.15% eye drops

Preservative-free

DRUG

0.9% saline eye drops

Preservative-free, one drop 4 times a day in each eye (run-in period)

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Global Trial Leader, Global Development Operations · Alcon, A Novartis Division

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-17
Primary Completion
2016-05-26
Completion
2016-05-26

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02470429 on ClinicalTrials.gov